Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma Outcomes
生物学、临床和社会决定因素对创伤和创伤结果的影响
基本信息
- 批准号:10344300
- 负责人:
- 金额:$ 25.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY / ABSTRACT
This T32 grant, Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma
Outcomes, will provide the training and mentoring to create the next generation of physician scientists.
Physician-scientists are a critical element of the workforce necessary to improve the health of patients.
Injuries and deaths from traumatic injury represent the major cause of death and impaired function among
people under the age of 44. This morbidity and mortality creates a disproportionate drain on healthcare
resources due to the typical young age of the trauma patient. Additionally, new advances in identifying the
scope of chronic traumatic encephalopathy (football players' brain injury) show the need for increased
investment in the basic science of trauma. Trauma also disproportionately affects underserved minority
patients, resulting in increased healthcare disparities in the United States. This highlights the need for
scientists who will lead studies to improve our understanding of and develop interventions to reduce
disparities in trauma care, risk of interpersonal violence (child abuse, intimate partner violence, elder
abuse) leading to trauma, and social determinants and trauma. This competing renewal will build on the
success of the prior ten years of funding. These successes include effective recruitment of minority
physicians into the program, 112 publications authored by 17 trainees, including 54 first-author
publications. Some of the significant changes in the new application include inclusion of health services
and population sciences faculty mentors to support and mentor trainees increasing interest in these areas
of research related to causes and outcomes of traumatic events. This grant specifically requests funding for
two postdoctoral fellows for two years of training, a formula which has proven successful since inception of
this training program. The Executive Committee works closely with the individual trainees to identify
mentors whose research matches the interests of the trainees. All of our prior trainees have been drawn
from the residency programs at Boston Medical Center, the largest safety net hospital in New England.
There is exceptional institutional commitment manifest by the support for the recruitment and retention of
minority physicians and trainees with disabilities. The productivity of trainees both during and after their
participation in this fellowship demonstrate that we have prepared our trainees for academic careers.
项目总结/摘要
这个T32补助金,生物,临床和社会决定因素对创伤和创伤的影响
结果,将提供培训和指导,以创造下一代的医生科学家。
医生-科学家是改善患者健康所需的劳动力的关键要素。
创伤性损伤造成的伤害和死亡是死亡和功能受损的主要原因,
44岁以下的人。这种发病率和死亡率对医疗保健造成了不成比例的消耗
由于创伤患者的典型年轻年龄,此外,在确定
慢性创伤性脑病(足球运动员脑损伤)的范围显示需要增加
对创伤基础科学的投资。创伤也不成比例地影响服务不足的少数群体
患者,导致美国医疗保健差距扩大。这突出了
科学家们将领导研究,以提高我们对减少艾滋病毒/艾滋病的理解,并制定干预措施,
创伤护理方面的差异、人际暴力风险(虐待儿童、亲密伴侣暴力、老年人暴力)
虐待)导致创伤,以及社会决定因素和创伤。这种竞争性的更新将建立在
过去十年的融资成功。这些成功包括有效招募少数族裔
医生进入该计划,112出版物撰写的17名学员,其中包括54第一作者
出版物。新应用程序中的一些重大变化包括纳入医疗服务
和人口科学系导师,以支持和指导学员对这些领域的兴趣日益增加
与创伤事件的原因和结果相关的研究。这笔赠款特别要求资助
两名博士后研究员接受两年培训,自成立以来,这一方案已被证明是成功的
这个训练计划。执行委员会与学员个人密切合作,
导师的研究符合学员的兴趣。我们之前所有的学员都被抽中了
波士顿医疗中心是新英格兰最大的安全网医院。
支持征聘和保留工作人员表明了特殊的体制承诺,
少数民族医生和残疾受训人员。培训期间和培训结束后,
参加这项研究表明,我们已经为学员的学术生涯做好了准备。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tony E Godfrey其他文献
Tony E Godfrey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tony E Godfrey', 18)}}的其他基金
Development of diagnostic and prognostic tests for esophageal adenocarcinoma
食管腺癌诊断和预后测试的发展
- 批准号:
10057357 - 财政年份:2016
- 资助金额:
$ 25.09万 - 项目类别:
Development of diagnostic and prognostic tests for esophageal adenocarcinoma
食管腺癌诊断和预后测试的发展
- 批准号:
10308014 - 财政年份:2016
- 资助金额:
$ 25.09万 - 项目类别:
Feasibility of Molecular Cytology for the Management of Barrett's Esophagus
分子细胞学治疗巴雷特食管的可行性
- 批准号:
8880446 - 财政年份:2015
- 资助金额:
$ 25.09万 - 项目类别:
Innovative approach to cancer detection and treatment monitoring
癌症检测和治疗监测的创新方法
- 批准号:
8643777 - 财政年份:2013
- 资助金额:
$ 25.09万 - 项目类别:
Innovative approach to cancer detection and treatment monitoring
癌症检测和治疗监测的创新方法
- 批准号:
8426388 - 财政年份:2013
- 资助金额:
$ 25.09万 - 项目类别:
Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma Outcomes
生物学、临床和社会决定因素对创伤和创伤结果的影响
- 批准号:
10616684 - 财政年份:2010
- 资助金额:
$ 25.09万 - 项目类别:
Biomarkers for Esophageal Cancer Progression and Prognosis
食管癌进展和预后的生物标志物
- 批准号:
7909276 - 财政年份:2009
- 资助金额:
$ 25.09万 - 项目类别:
Biomarkers for Esophageal Cancer Progression and Prognosis
食管癌进展和预后的生物标志物
- 批准号:
7687433 - 财政年份:2008
- 资助金额:
$ 25.09万 - 项目类别:
Biomarkers for Esophageal Cancer Progression and Prognosis
食管癌进展和预后的生物标志物
- 批准号:
7523588 - 财政年份:2008
- 资助金额:
$ 25.09万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
EAGER: Integrating Pathological Image and Biomedical Text Data for Clinical Outcome Prediction
EAGER:整合病理图像和生物医学文本数据进行临床结果预测
- 批准号:
2412195 - 财政年份:2024
- 资助金额:
$ 25.09万 - 项目类别:
Standard Grant
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10778757 - 财政年份:2023
- 资助金额:
$ 25.09万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 25.09万 - 项目类别:
Synergistic clinical outcome assessments for cervical dystonia
颈肌张力障碍的协同临床结果评估
- 批准号:
10624087 - 财政年份:2023
- 资助金额:
$ 25.09万 - 项目类别:
Randomized comparison of the clinical Outcome of single versus Multiple Arterial grafts in Women (ROMA: Women trial)
女性单动脉移植与多动脉移植临床结果的随机比较(ROMA:女性试验)
- 批准号:
479156 - 财政年份:2023
- 资助金额:
$ 25.09万 - 项目类别:
Operating Grants
Developing a Clinical Outcome Assessment for Opioid Craving Using Patient Feedback (DDT-COA-000138)
利用患者反馈制定阿片类药物渴求的临床结果评估 (DDT-COA-000138)
- 批准号:
10834309 - 财政年份:2023
- 资助金额:
$ 25.09万 - 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10783106 - 财政年份:2023
- 资助金额:
$ 25.09万 - 项目类别:
Feasibility and outcome measures for infants with Down syndrome: Advancing clinical trial readiness for a harness-based mobility intervention
唐氏综合症婴儿的可行性和结果测量:推进基于安全带的活动干预的临床试验准备
- 批准号:
10656637 - 财政年份:2023
- 资助金额:
$ 25.09万 - 项目类别:
Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
创建和验证剂量阿片类药物来源评估工具 (DOSE) - 稳健的阿片类药物使用临床结果评估,以获得 FDA 医疗器械开发工具 (MDDT) 资格
- 批准号:
10739706 - 财政年份:2023
- 资助金额:
$ 25.09万 - 项目类别:
Defining outcome measures for medication adherence in clinical trials.
定义临床试验中药物依从性的结果测量。
- 批准号:
2907089 - 财政年份:2023
- 资助金额:
$ 25.09万 - 项目类别:
Studentship